Home > Riviste > Italian Journal of Vascular and Endovascular Surgery > Fascicoli precedenti > Italian Journal of Vascular and Endovascular Surgery 2015 March;22(1) > Italian Journal of Vascular and Endovascular Surgery 2015 March;22(1):15-9

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Estratti
Per citare questo articolo

ITALIAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY

Rivista di Chirurgia Vascolare ed Endovascolare


Official Journal of the Italian Society of Vascular and Endovascular Surgery
Indexed/Abstracted in: EMBASE, Emerging Sources Citation Index, Scopus


eTOC

 

ORIGINAL ARTICLES  


Italian Journal of Vascular and Endovascular Surgery 2015 March;22(1):15-9

Copyright © 2015 EDIZIONI MINERVA MEDICA

lingua: Inglese

Hybrid revascularization for iliac-femoral obstructive disease

Piffaretti G. 1, Rivolta N. 1, Bossi M. 1, Fontana F. 2, Piacentino F. 2, Castelli P. 1

1 Unit of Vascular Surgery, Department of Surgery and Morphological Sciences, Varese University Hospital, University of Insubria School of Medicine, Varese, Italy; 2 Unit of Interventional Radiology, Department of Surgery and Morphological Sciences, Varese University Hospital, University of Insubria School of Medicine, Varese, Italy


PDF  


AIM: The aim of this paper was to report mid-term outcomes of hybrid revascularization for iliac-femoral obstructive disease combining open common femoral endarterectomy and iliac artery stenting.
METHODS: Between January 2004 and March 2012, 44 patients were included into the analysis. It is a single center experience with a retrospective analysis of the data. Preoperatively, all patients underwent echo-color-Doppler and computed tomography angiography (CT-A) to assess aorto-iliac and femoro-popliteal vessels. All the interventions were performed in the operating theatre equipped with a mobile C-arm. Follow-up included clinical visit with Ankle-Brachial Index (ABI) and echo-color-Doppler at 6-month-intervals during the first year, and once per year thereafter.
RESULTS: Operative indication was severe claudication (N.=29, 69.0%), rest pain (N.=12, 27.3%), and tissue loss (N.=3, 6.8%). TASC D lesion was observed in 19 (43.2%) cases, bilateral lesions were 16 (36.4%). Occlusion was present in 22 (50.0%) cases. The technical success rate was 100%. Mean hospitalization was 5.9±2.8 days (range, 2-15). In-hospital mortality occurred in 1 (2.4%) case (stroke N.=1). No early thrombosis was observed. The mean follow-up was 24.2±21.6 months (range, 1-84; median, 12). Primary patency was 89.6% at 1 year, and 82.7% at 3 and 5 years. Major or minor amputations were never required.
CONCLUSION: In our experience, hybrid treatment for iliac-femoral obstructive disease is a safe and viable alternative to conventional open bypasses.

inizio pagina

Publication History

Per citare questo articolo

Piffaretti G, Rivolta N, Bossi M, Fontana F, Piacentino F, Castelli P. Hybrid revascularization for iliac-femoral obstructive disease. Ital J Vasc Endovasc Surg 2015 March;22(1):15-9. 

Corresponding author e-mail